Mindfulness Meditation Combined With Progressive Muscle Relaxation Training for Uremic Sarcopenia

NCT ID: NCT06261372

Last Updated: 2024-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-15

Study Completion Date

2023-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To study the effect of mindfulness meditation combined with progressive muscle relaxation training on clinical efficacy and quality of life in maintenance hemodialysis (MHD) patients with sarcopenia. Eligible sarcopenic patients in our hospital were randomly assigned to a control group (n = 24) and an intervention group (n = 25). The control group received conventional dialysis treatment, while the intervention group received mindfulness meditation combined with progressive muscle relaxation training during the interdialysis period in addition to conventional dialysis treatment. The effect of the intervention was evaluated after 12 weeks.To observe whether the combined intervention training can improve the motor ability and quality of life of patients with sarcopenia in a short period of time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis Patients With Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

The control group received conventional dialysis treatment.

Group Type NO_INTERVENTION

No interventions assigned to this group

intervention group

In addition to conventional treatment, mindfulness meditation combined with progressive muscle relaxation training was implemented during the interdialytic period.

Group Type OTHER

The mindfulness meditation combined with progressive muscle relaxation training .

Intervention Type BEHAVIORAL

The first part is progressive muscle relaxation training. The second part is mindfulness meditation training.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The mindfulness meditation combined with progressive muscle relaxation training .

The first part is progressive muscle relaxation training. The second part is mindfulness meditation training.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who met the sarcopenia criteria established by the Asian Working Group for Sarcopenia (AWGS) in 2014
* Stable condition and generally good health status
* Good compliance and ability to collaborate well with the physician
* Undergoing hemodialysis three times per week for at least three months, with a KT/V ≥ 1.2
* No significant cardiovascular or cerebrovascular complications (such as severe heart failure, severe arrhythmias, angina, and cerebrovascular diseases)
* Patients with sarcopenia who met the clinical diagnostic criteria were selected to ensure the quality of the included patients

Exclusion Criteria

* Inability to complete handgrip strength, 6-meter walk test, 10 sit-to-stand tests, and the use of bioelectrical impedance analysis (BIA) due to contraindications
* Coexistence of mental illness or severe cognitive or communication disorders
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ningbo Medical Center Lihuili Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Li Huili Hospital, Ningbo Medical Center

Ningbo, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Wu Y, Zhang H, Jiang L, Liu Z, Li X, Guo B, Li J, Xu P, Liu J, Yu R. Effects of mindfulness meditation combined with progressive muscle relaxation on sleep disorders, anxiety, and depression in patients with sarcopenia undergoing hemodialysis. Front Psychiatry. 2025 Jun 13;16:1542028. doi: 10.3389/fpsyt.2025.1542028. eCollection 2025.

Reference Type DERIVED
PMID: 40585548 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KY2023PJ204

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pranayama Practice on the Autonomic Nervous System
NCT03280589 COMPLETED EARLY_PHASE1
Qigong Exercise and Sleep Quality
NCT06532864 COMPLETED NA